Even though a direct mechanistic link between PCSK9 levels and total Tau and phospho-Tau has not been established, the strong positive correlations that exist between those CSF biomarkers in “at-risk” subjects may indicate a subclinical interaction that might increase the risk of cognitive decline. The gene discussed is MAPT; the disease is Mental deterioration.